Skip Navigation

This Article
Right arrow Print PDF (892K)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (38)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Stahl, S.
Right arrow Articles by Uhlén, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stahl, S.
Right arrow Articles by Uhlén, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 1988, Vol. 16, No. 7 3025-3038
© 1988

Articles

Solid phase DNA sequencing using the biotin-avidin system

Stefan Stahl, Thomas Hultman, Anders Olsson*, Tomas Moks and Mathias Uhlén+

Department of Biochemistry, Royal Institute of Technology S-10044 Stockholm, Sweden

+To whom correspondence should be addressed

Received December 23, 1987. Revised February 19, 1988. Accepted February 19, 1988.

A novel method for solid-phase DNA sequencing is described. A plasmid vector, pRIT27, has been designed to allow directional immobilization of double stranded plasmid to avidin agarose. The strategy involves enzymatic incorporation of 11-bio-dUTP into the plasmid and strand specific elution using alkali. The immobilized single stranded DNA is used as template for sequencing re actions and the resulting labelled oligonucleotides are eluted by alkali. The affinity gel containing the immobilized template is consecutively used for the four different dideoxy-nucleotide reactions. The solid-phase technique can be used for both primer specific or extension specific labelling. The possibility to use the system in automated DNA sequencing is discussed.

*Present address: Pharmacia-LKB Biotechnology, Bromma, Sweden


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Ann OncolHome page
J. Andersson, L. Larsson, S. Klaar, L. Holmberg, J. Nilsson, M. Inganas, G. Carlsson, J. Ohd, C.-M. Rudenstam, B. Gustavsson, et al.
Worse survival for TP53 (p53)-mutated breast cancer patients receiving adjuvant CMF
Ann. Onc., May 1, 2005; 16(5): 743 - 748.
[Abstract] [Full Text] [PDF]

Home page
 Genome ResHome page
A. Alderborn, A. Kristofferson, and U. Hammerling
Determination of Single-Nucleotide Polymorphisms by Real-time Pyrophosphate DNA Sequencing
Genome Res., August 1, 2000; 10(8): 1249 - 1258.
[Abstract] [Full Text]

Home page
 JCOHome page
U. Kressner, M. Inganas, S. Byding, I. Blikstad, L. Pahlman, B. Glimelius, and G. Lindmark
Prognostic Value of p53 Genetic Changes in Colorectal Cancer
J. Clin. Oncol., February 1, 1999; 17(2): 593 - 593.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.